Literature DB >> 21798960

Skeletal muscle mitochondrial function in polycystic ovarian syndrome.

Rasmus Rabøl1, Pernille F Svendsen, Mette Skovbro, Robert Boushel, Peter Schjerling, Lisbeth Nilas, Sten Madsbad, Flemming Dela.   

Abstract

OBJECTIVE: Polycystic ovarian syndrome (PCOS) is associated with skeletal muscle insulin resistance (IR), which has been linked to decreased mitochondrial function. We measured mitochondrial respiration in lean and obese women with and without PCOS using high-resolution respirometry.
METHODS: Hyperinsulinemic-euglycemic clamps (40  mU/min per m(2)) and muscle biopsies were performed on 23 women with PCOS (nine lean (body mass index (BMI) <25 kg/m(2)) and 14 obese (BMI >25 kg/m(2))) and 17 age- and weight-matched controls (six lean and 11 obese). Western blotting and high-resolution respirometry was used to determine mitochondrial function.
RESULTS: Insulin sensitivity decreased with PCOS and increasing body weight. Mitochondrial respiration with substrates for complex I and complex I+II were similar in all groups, and PCOS was not associated with a decrease in mitochondrial content as measured by mitochondrial DNA/genomic DNA. We found no correlation between mitochondrial function and indices of insulin sensitivity.
CONCLUSIONS: In contrast to previous reports, we found no evidence that skeletal muscle mitochondrial respiration is reduced in skeletal muscle of women with PCOS compared with control subjects. Furthermore, mitochondrial content did not differ between our control and PCOS groups. These results question the causal relationship between reduced mitochondrial function and skeletal muscle IR in PCOS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21798960     DOI: 10.1530/EJE-11-0419

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  7 in total

Review 1.  Polycystic ovary syndrome in mitochondrial disorders due mtDNA or nDNA variants.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Am J Transl Res       Date:  2018-01-15       Impact factor: 4.060

2.  Peripheral insulin resistance in obese girls with hyperandrogenism is related to oxidative phosphorylation and elevated serum free fatty acids.

Authors:  Melanie Cree-Green; Bradley R Newcomer; Gregory Coe; Lindsey Newnes; Amy Baumgartner; Mark S Brown; Laura Pyle; Jane E Reusch; Kristen J Nadeau
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-02-24       Impact factor: 4.310

3.  Defects in mitochondrial efficiency and H2O2 emissions in obese women are restored to a lean phenotype with aerobic exercise training.

Authors:  Adam R Konopka; Albert Asante; Ian R Lanza; Matthew M Robinson; Matthew L Johnson; Chiara Dalla Man; Claudio Cobelli; Mark H Amols; Brian A Irving; K S Nair
Journal:  Diabetes       Date:  2015-01-20       Impact factor: 9.461

4.  Non-cell autonomous mechanisms control mitochondrial gene dysregulation in polycystic ovary syndrome.

Authors:  Alba Moreno-Asso; Ali Altıntaş; Luke C McIlvenna; Rhiannon K Patten; Javier Botella; Andrew J McAinch; Raymond J Rodgers; Romain Barrès; Nigel K Stepto
Journal:  J Mol Endocrinol       Date:  2021-12-03       Impact factor: 5.098

5.  Mitochondrial respiratory capacity and content are normal in young insulin-resistant obese humans.

Authors:  Kelsey H Fisher-Wellman; Todd M Weber; Brook L Cathey; Patricia M Brophy; Laura A A Gilliam; Constance L Kane; Jill M Maples; Timothy P Gavin; Joseph A Houmard; P Darrell Neufer
Journal:  Diabetes       Date:  2013-08-23       Impact factor: 9.461

6.  Altered cardiorespiratory response to exercise in overweight and obese women with polycystic ovary syndrome.

Authors:  Antti-Pekka E Rissanen; Tiina Koskela-Koivisto; Harriet Hägglund; Anne S Koponen; Jyrki M Aho; Maritta Pöyhönen-Alho; Aila Tiitinen; Heikki O Tikkanen; Juha E Peltonen
Journal:  Physiol Rep       Date:  2016-02

Review 7.  The mitochondrial profile in women with polycystic ovary syndrome: impact of exercise.

Authors:  Melpomeni Malamouli; Itamar Levinger; Andrew J McAinch; Adam J Trewin; Raymond J Rodgers; Alba Moreno-Asso
Journal:  J Mol Endocrinol       Date:  2022-03-01       Impact factor: 5.098

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.